MTNB icon

Matinas BioPharma
MTNB

Overview Fund Activity

47 hedge funds and large institutions have $3.37M invested in Matinas BioPharma in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 8 closing their positions.

Holders
47
Holders Change
-4
Holders Change %
-7.84%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$98.1K
2
Squarepoint
2
Squarepoint
New York
$19.2K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$28K
4
PAG
4
Private Advisor Group
New Jersey
$33.5K
5
TRCT
5
Tower Research Capital (TRC)
New York
$6.07K

Top Sellers

1
CCM
1
Courage Capital Management
Tennessee
$0
2
VF
2
Virtu Financial
New York
$0
3
Charles Schwab
3
Charles Schwab
California
$0
4
SCA
4
STALEY CAPITAL ADVISERS
Pennsylvania
$52K
5
GRP
5
Global Retirement Partners
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GRP
51
Global Retirement Partners
California
– -$18K -1,000 Closed
AWS
52
Atria Wealth Solutions
New York
– -$14.2K -788 Closed
Millennium Management
53
Millennium Management
New York
– -$6.4K -356 Closed
UBS Group
54
UBS Group
Switzerland
– -$5.15K -286 Closed
HF
55
HRT Financial
New York
– -$3K -205 Closed
1 2
3